These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 875896)

  • 21. Reducing uncertainty in risk assessment by using specific knowledge to replace default options.
    McClellan RO
    Drug Metab Rev; 1996; 28(1-2):149-79. PubMed ID: 8744594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A proposed framework for assessing risk from less-than-lifetime exposures to carcinogens.
    Felter SP; Conolly RB; Bercu JP; Bolger PM; Boobis AR; Bos PM; Carthew P; Doerrer NG; Goodman JI; Harrouk WA; Kirkland DJ; Lau SS; Llewellyn GC; Preston RJ; Schoeny R; Schnatter AR; Tritscher A; van Velsen F; Williams GM
    Crit Rev Toxicol; 2011 Jul; 41(6):507-44. PubMed ID: 21591905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dyes metabolized to benzidine (benzidine dye class).
    Rep Carcinog; 2004; 11():III29-31. PubMed ID: 21089810
    [No Abstract]   [Full Text] [Related]  

  • 24. Breast cancer risk and environmental exposures.
    Wolff MS; Weston A
    Environ Health Perspect; 1997 Jun; 105 Suppl 4(Suppl 4):891-6. PubMed ID: 9255576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Understanding population and individual risk assessment: the case of polychlorinated biphenyls.
    Shields PG
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):830-9. PubMed ID: 16702358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update of potency factors for asbestos-related lung cancer and mesothelioma.
    Berman DW; Crump KS
    Crit Rev Toxicol; 2008; 38 Suppl 1():1-47. PubMed ID: 18671157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biologically based models for risk assessment.
    Portier CJ; Hoel DG; Kaplan NL; Kopp A
    IARC Sci Publ; 1990; (104):20-8. PubMed ID: 2228117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benzidine and its sulphate, hydrochloride and dihydrochloride.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1982 May; 29():149-83. PubMed ID: 6957380
    [No Abstract]   [Full Text] [Related]  

  • 29. Contemporary trends in in vivo and in vitro testing of chemical carcinogens.
    Slamenová D
    Neoplasma; 2001; 48(6):425-34. PubMed ID: 11949832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Criteria, rules and procedures adopted by IARC in evaluating risks from different carcinogenic agents for humans].
    IARC
    Vopr Onkol; 2007; 53(6):621-41. PubMed ID: 18416130
    [No Abstract]   [Full Text] [Related]  

  • 31. Summary of the National Toxicology Program benzidine dye initiative.
    Morgan DL; Dunnick JK; Goehl T; Jokinen MP; Matthews HB; Zeiger E; Mennear JH
    Environ Health Perspect; 1994 Jun; 102 Suppl 2(Suppl 2):63-78. PubMed ID: 7925189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. To BaP or not to BaP? That is the question.
    Goldstein LS
    Environ Health Perspect; 2001 Aug; 109(8):A356-7. PubMed ID: 11564626
    [No Abstract]   [Full Text] [Related]  

  • 33. Trichloroethylene health risks--state of the science.
    Scott CS; Cogliano VJ
    Environ Health Perspect; 2000 May; 108 Suppl 2(Suppl 2):159-60. PubMed ID: 10928830
    [No Abstract]   [Full Text] [Related]  

  • 34. Editorial: The Delaney Clause.
    Coon JM
    Prev Med; 1973 Mar; 2(1):150-5. PubMed ID: 4378415
    [No Abstract]   [Full Text] [Related]  

  • 35. [Prevention of carcinogenicity risks in work environment].
    Terracini B
    Med Lav; 1998; 89(2):98-101. PubMed ID: 9673098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Approaches to cancer assessment in EPA's Integrated Risk Information System.
    Gehlhaus MW; Gift JS; Hogan KA; Kopylev L; Schlosser PM; Kadry AR
    Toxicol Appl Pharmacol; 2011 Jul; 254(2):170-80. PubMed ID: 21034767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arsenic exposure and bladder cancer: quantitative assessment of studies in human populations to detect risks at low doses.
    Tsuji JS; Alexander DD; Perez V; Mink PJ
    Toxicology; 2014 Mar; 317():17-30. PubMed ID: 24462659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benzidine.
    National Toxicology Program
    Rep Carcinog; 2002; 10():26-8. PubMed ID: 15317128
    [No Abstract]   [Full Text] [Related]  

  • 39. FIFRA Subdivision F testing Guidelines: are these tests adequate to detect potential hormonal activity for crop protection chemicals? Federal Insecticide, Fungicide, and Rodenticide Act.
    Stevens JT; Tobia A; Lamb JC; Tellone C; O'Neal F
    J Toxicol Environ Health; 1997 Apr; 50(5):415-31. PubMed ID: 9140462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative risk assessment and the limitations of the linearized multistage model.
    Lovell DP; Thomas G
    Hum Exp Toxicol; 1996 Feb; 15(2):87-104. PubMed ID: 8645508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.